Switch from ritonavir to indinavir in combination therapy for HIV-1-infected childrenPELTON, Stephen I; STANLEY, Kenneth; YOGEV, Ram et al.Clinical infectious diseases. 2005, Vol 40, Num 8, pp 1181-1187, issn 1058-4838, 7 p.Article

Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1KROGSTAD, Paul; ESHLEMAN, Susan H; PALUMBO, Paul et al.AIDS research and human retroviruses. 2002, Vol 18, Num 6, pp 413-417, issn 0889-2229Article

Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and serorevertersMELLINS, Claude Ann; BRACKIS-COTT, Elizabeth; LEU, Cheng-Shiun et al.Journal of child psychology and psychiatry and allied disciplines (Print). 2009, Vol 50, Num 9, pp 1131-1138, issn 0021-9630, 8 p.Article

Sexual and Drug Use Behavior in Perinatally HIV-Infected Youth: Mental Health and Family InfluencesMELLINS, Claude A; ELKINGTON, Katherine S; BAUERMEISTER, Jose A et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2009, Vol 48, Num 8, pp 810-819, issn 0890-8567, 10 p.Article

Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (pediatric AIDS Clinical Trials Group 377)ESHLEMAN, Susan H; KROGSTAD, Paul; NACHMAN, Sharon et al.The Journal of infectious diseases. 2001, Vol 183, Num 12, pp 1732-1738, issn 0022-1899Article

Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youthMELLINS, Claude A; ELKINGTON, Katherine S; LEU, Cheng-Shiun et al.AIDS Care (Print). 2012, Vol 24, Num 7-8, pp 953-962, issn 0954-0121, 10 p.Conference Paper

CD4⁺ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy InterruptionSIBERRY, George K; PATEL, Kunjal; VAN DYKE, Russell B et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 57, Num 3, pp 223-229, issn 1525-4135, 7 p.Article

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1KROGSTAD, Paul; LEE, Sophia; MENDEZ, Hermann et al.Clinical infectious diseases. 2002, Vol 34, Num 7, pp 991-1001, issn 1058-4838Article

Growth in Human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapyNACHMAN, Sharon A; LINDSEY, Jane C; PELTON, Stephen et al.Archives of pediatrics & adolescent medicine. 2002, Vol 156, Num 5, pp 497-503, issn 1072-4710Conference Paper

Varicella-zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapyWEINBERG, Adriana; WIZNIA, Andrew A; LAFLEUR, Bonnie J et al.The Journal of infectious diseases. 2004, Vol 190, Num 2, pp 267-270, issn 0022-1899, 4 p.Article

Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 YearsNACHMAN, Sharon; NAN ZHENG; FRENKEL, Lisa M et al.Clinical infectious diseases. 2014, Vol 58, Num 3, pp 413-422, issn 1058-4838, 10 p.Article

Monitoring of HIV Type 1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells During Suppressive Antiretroviral Therapy Does Not Predict Virologic FailureBECK, Ingrid A; JANG, Minyoung; WIZNIA, Andrew et al.AIDS research and human retroviruses. 2012, Vol 28, Num 8, pp 780-788, issn 0889-2229, 9 p.Article

CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1―Infected Children Receiving Highly Active Antiretroviral TherapySAITOH, Akihiko; CAPPARELLI, Edmund; SPECTOR, Stephen A et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 3, pp 285-289, issn 1525-4135, 5 p.Article

Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected childrenJEREMY, Rita J; KIM, Soyeon; STANLEY, Kenneth et al.Pediatrics (Evanston). 2005, Vol 115, Num 2, pp 380-387, issn 0031-4005, 8 p., 1Article

Higher frequency of HIV-1-specific T cell immune responses in african american children vertically infected with HIV-1. CommentaryKOVACS, Andrea; VILLACRES, Maria C; SHARP, Elizabeth R et al.The Journal of infectious diseases. 2005, Vol 192, Num 10, pp 1683-1685, issn 0022-1899, 12 p.Article

I feel like I'm carrying a weapon. Information and motivations related to sexual risk among girls with perinatally acquired HIVMARHEFKA, Stephanie L; VALENTIN, Cidna R; PINTO, Rogerio M et al.AIDS Care (Print). 2011, Vol 23, Num 10, pp 1321-1328, issn 0954-0121, 8 p.Article

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected childrenSAITOH, Akihiko; SARLES, Elizabeth; CAPPARELLI, Edmund et al.AIDS (London). 2007, Vol 21, Num 16, pp 2191-2199, issn 0269-9370, 9 p.Article

Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-lnfected childrenABADI, Jacobo; SPRECHER, Eli; ROSENBERG, Michael G et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 41, Num 3, pp 298-303, issn 1525-4135, 6 p.Article

Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents : Pediatric Aids Clinical Trials Group protocol 403KING, Jennifer R; NACHMAN, Sharon; YOGEV, Ram et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 10, pp 880-885, issn 0891-3668, 6 p.Article

Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected childrenKING, Jennifer R; NACHMAN, Sharon; YOGEV, Ram et al.Antiviral therapy (London). 2002, Vol 7, Num 4, pp 267-270, issn 1359-6535, 4 p.Article

Cytomegalovims-specific cell-mediated immunity in HIV-infected children on HAARTWEINBERG, Adriana; WIZNIA, Andrew A; LAFLEUR, Bonnie J et al.AIDS research and human retroviruses. 2006, Vol 22, Num 3, pp 283-288, issn 0889-2229, 6 p.Article

Association between skin testing in the pediatric emergency department and adherence to follow-up in children with asthmaSCARFI, Catherine A; CUNNINGHAM, Sandra J; WIZNIA, Andrew et al.Annals of allergy, asthma, & immunology. 2009, Vol 102, Num 1, pp 35-40, issn 1081-1206, 6 p.Article

Steady-State Pharmacokinetics of Tenofovir-Based Regimens in HIV-Infected Pediatric PatientsKING, Jennifer R; YOGEV, Ram; JEAN-PHILIPPE, Patrick et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4290-4294, issn 0066-4804, 5 p.Article

STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTSKING, Jennifer R; ACOSTA, Edward P; WATSON, Douglas et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 2, pp 159-161, issn 0891-3668, 3 p.Article

Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patientsWIZNIA, Andrew; CHURCH, Joseph; EMMANUEL, Patricia et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 9, pp 799-805, issn 0891-3668, 7 p.Article